• Wednesday
  • September 17, 2014
  • Last updated: 7:58am
Hong Kong




Refine Your Search

Sort by

Search Results

Results 1 - 10 of 5863 for baoshantang pharmaceutical company

Related topics matching your search

Search results

  1. Small drugmakers struggle to meet stricter regulations

    Posted Nov 08th 2003, 12:00am by Staff Reporter

    ... some bargains as cash-strapped smaller companies faced difficulties in upgrading their facilities as required under stricter mainland health-care regulations. Far East Pharmaceutical ... Winston Yau in Shenzhen Bigger players are poised to swoop on cash-strapped firms that do not comply Beijing's tighter bank credit policy has forced China's weaker pharmaceutical ...

  2. Increased production boosts China Pharmaceutical

    Posted Aug 13th 2003, 12:00am by Staff Reporter

    ... China Pharmaceutical Group more than tripled its first-half net profit to $359.36 million from $101.16 million last year on the back of an increase in bulk drug production. The group's turnover increased 93 per cent to $1.36 billion, with penicillin output rising 41 per cent to 2,542 tonnes and production of 7-ACA antibiotic materials growing 52 per cent to 314 tonnes. ...

  3. Depression pills 'make kids suicidal'

    Posted Sep 24th 2003, 12:00am by Staff Reporter

    ... a number of serious and urgent questions about the conduct of the British pharmaceutical industry, the use of drugs for children and the MHRA's ability to monitor drug companies. 'We want ... made by the drug company Wyeth, is being taken by at least 3,000 children in the UK, despite recommendations to doctors that it should not be given to anyone under 18, the report said. ...

  4. Vice-premier hears piracy petitions

    Posted Sep 19th 2003, 12:00am by Staff Reporter

    ... products made in China, ranging from car parts and playing cards to pharmaceuticals and pirated DVDs, were costing US companies US$20 billion to $25 billion each year, Mr Lash said. 'Obviously ... Multinational companies seek to get better protection for their brands in their meeting with Wu Yi A group of multinational corporations last week met Vice-Premier Wu Yi to push for better ...

  5. Broad Intelligence seeks to raise $78m

    Posted Nov 11th 2003, 12:00am by Toh Han Shih

    ... Toh Han Shih Mainland drug firm Broad Intelligence International Pharmaceutical Holdings is seeking to raise about $78 million from a listing on the main board. The company's 97.2 ... are listing in Hong Kong to raise our international profile. We are expanding internationally. Southeast Asia is expected to grow rapidly to become a major market for the company apart from ...

  6. Upgrades and downgrades

    Posted Aug 15th 2003, 12:00am by David Robinson

    ... will be capped at $15. The shares ended at $13.60 yesterday. BUY China Pharmaceutical Kim Eng has reiterated its 'buy' rating on China Pharmaceutical after first-half results at the high end of market consensus. The drug company's turnover increased 93 per cent to HK$1.36 billion and net profit rose 255 per cent to HK$359.4 million. Analyst Dennis Lam said strong vitamin C prices ...

  7. Investors can choose own health risk

    Posted Aug 17th 2003, 12:00am by Jane Parry

    ... will invest in the world's 12 largest pharmaceutical and health-care stocks. The top 10 pharmaceutical companies account for 49 per cent of market share, so this fund gives investors easy access ... cent of sales hold the most interest, and fund manager Caspar Rock says the fund's bias away from big pharmaceutical companies will be to its advantage in the coming year. 'We ...

  8. Cepa spurs CK Life to reconsider bases

    Posted Dec 11th 2003, 12:00am by Staff Reporter

    ... According to the company's annual report, its products cover five areas: eco-agriculture, bioremediation, pharmaceuticals, nutraceuticals and dermatologicals. A subsidiary, CK Life Sciences, ... economic partnership arrangement (Cepa) with the mainland. In a panel discussion yesterday, the company's chairman, Victor Li Tzar-kuoi, revealed the relocation plan in response to a question ...

  9. Hutchison forms $1.86b Chinese medicine venture

    Posted Dec 13th 2003, 12:00am by Ben Kwok

    ... Chinese-medicine firm, China Beijing Tongrentang (Group), to develop traditional cures. The conglomerate yesterday set up a 49-49 joint venture, Beijing Tongrentang Hutchison Pharmaceutical Investment, ... to speed up their investment in traditional Chinese medicine and health-related projects and enterprises. 'We hope that China's pharmaceutical business will expand further, ...

  10. Appointments

    Posted Sep 13th 2003, 12:00am by Staff Reporter

    ... the company's marketing initiatives. He will be responsible for orchestrating Microsoft's business and product marketing strategies, creating marketing excellence through talent management, systems ... Before joining the company, he was with Citigroup Smith Barney. Joseph Tobing Research analyst ABN Amro A research analyst based in Jakarta, Mr Tobing joins ABN Amro with seven years' ...




SCMP.com Account